INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 43h ago
HOUSE PTR3h ago
SEC 13F3h ago
ROBINHOOD CHAIN3h ago
Corporate insider
PT

Plott Ronald Todd

DirectorCIK 0001768337

EDGAR filingsOpen in network
Disclosed transactions4
Buys / sells3 / 0
Max Insider Score41
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
39
PT
Plott Ronald ToddDirector
PHIOPhio Pharmaceuticals Corp.
Open-market purchase
BUY$5,200
5,000 sh
Sep 29, 2026Sep 30, 2026
traded Sep 29, 2026
+1dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Phio Pharmaceuticals Corp.Director · Aug 20, 2026
39
PT
Plott Ronald ToddDirector
PHIOPhio Pharmaceuticals Corp.
Open-market purchase
BUY
$5,150
5,000 sh
Sep 28, 2026
Sep 30, 2026
traded Sep 28, 2026
+2d
SEC FORM 4

Evidence

17
PT
Plott Ronald ToddDirector
PHIOPhio Pharmaceuticals Corp.
Grant or award
A—
17.0K sh
Sep 28, 2026Sep 29, 2026
traded Sep 28, 2026
+1dSEC FORM 4

Evidence

41
PT
Plott Ronald ToddDirector
PHIOPhio Pharmaceuticals Corp.
Open-market purchase
BUY$17K
15.0K sh
Aug 19, 2026Aug 20, 2026
traded Aug 19, 2026
+1dSEC FORM 4

Evidence